Cardiac sympathetic hypo-innervation in familial dysautonomia

Clinical Autonomic Research

Volumn 18, Issue 3, 2008, Pages 115-119

  Goldstein, David S ^a   Eldadah, Basil ^a   Sharabi, Yehonatan ^a   Axelrod, Felicia B ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Familial dysautonomia; Fluorodopamine; Norepinephrine; Positron emission tomography; Sympathetic nervous system

Indexed keywords

DESIPRAMINE; FLUORODOPAMINE F 18; TRACER;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC DENERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DYSAUTONOMIA; FEMALE; HEART FUNCTION; HEART INNERVATION; HEART MUSCLE; HUMAN; MALE; NEUROIMAGING; NORADRENERGIC SYSTEM; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SYMPATHETIC INNERVATION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; CATECHOLAMINES; DESIPRAMINE; DOPAMINE; DYSAUTONOMIA, FAMILIAL; FEMALE; FLUORINE RADIOISOTOPES; HEART; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; POSITRON-EMISSION TOMOGRAPHY; SYMPATHETIC NERVOUS SYSTEM;

EID: 44749084587     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10286-008-0464-1     Document Type: Article

References (24)

1. Axelrod FB (2006) A world without pain or tears. Clin Auton Res 16:90-96
2. Axelrod FB, Goldberg JD, Ye XY, Maayan C (2002) Survival in familial dysautonomia: impact of early intervention. J Pediatr 141:518-523
3. Close P, Hawkes N, Cornez I, Creppe C, Lambert CA, Rogister B, Siebenlist U, Merville MP, Slaugenhaupt SA, Bours V, Svejstrup JQ, Chariot A (2006) Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell 22:521-531
4. Freedman LS, Ebstein RP, Goldstein M, Axelrod FB, Dancis J (1975) Serum dopamine-beta-hydroxylase in familial dysautonomia. J Lab Clin Med 85:1008-1012
5. Glickstein JS, Axelrod FB, Friedman D (1999) Electrocardiographic repolarization abnormalities in familial dysautonomia: an indicator of cardiac autonomic dysfunction. Clin Auton Res 9:109-112
6. Gold-von Simson G, Rutkowski M, Berlin D, Axelrod FB (2005) Pacemakers in patients with familial dysautonomia-a review of experience with 20 patients. Clin Auton Res 15:15-20
7. Goldstein DS, Eisenhofer G, Dunn BB, Armando I, Lenders J, Grossman E, Holmes C, Kirk KL, Bacharach S, Adams R, Herscovitch P, Kopin IJ (1993) Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol 22:1961-1971
8. Goldstein DS, Grossman E, Tamrat M, Chang PC, Eisenhofer G, Bacher J, Kirk KL, Bacharach S, Kopin IJ (1991) Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertens 9:417-423
9. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO 3rd (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338-347
10. Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JWM, Kopin IJ (1997) 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function-studies in normal humans. Clin Auton Res 7:17-29
11. Goldstein DS, Katzper M, Linares OA, Kopin IJ (2002) Kinetic model for the fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in the human heart: a novel means to assess cardiac sympathetic neuronal function. Naunyn-Schmiedeberg's Arch Pharmacol 365:38-49
12. Goodall MC, Gitlow SE, Alton H (1971) Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia. J Clin Invest 50:2734-2740
13. Kashihara K, Ohno M, Kawada S, Okumura Y (2006) Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 47:1099-1101
14. Pearson J, Brandeis L, Goldstein M (1979) Tyrosine hydroxylase immunoreactivity in familial dysautonomia. Science 206:71-72
15. Pearson J, Dancis J, Axelrod F, Grover N (1975) The sural nerve in familial dysautonomia. J Neuropathol Exp Neurol 34:413-424
16. Pearson J, Gallo G, Gluck M, Axelrod F (1980) Renal disease in familial dysautonomia. Kidney Int 17:102-112
17. Pearson J, Pytel BA (1978) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 39:47-59
18. Rotstein A, Charrow J, Deal BJ (2007) Documented transient third-degree atrioventricular block and asystole in a child with familial dysautonomia. Pediatr Cardiol
19. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598-605
20. Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429-436
21. Smith AA, Taylor T, Wortis B (1963) Abnormal catechol amine metabolism in familial dysautonomia. N Engl J Med 268:705-707
22. Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, Sakajiri K, Tonami N (2000) Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566-573
23. Weinshilboum RM, Axelrod J (1971) Reduced plasma dopamine-beta- hydroxylase activity in familial dysautonomia. N Engl J Med 285:938-942
24. Ziegler MG, Lake CR, Kopin IJ (1976) Deficient sympathetic nervous response in familial dysautonomia. N Engl J Med 294:630-633